• Nenhum resultado encontrado

In vitro Antimicrobial Activity of Linezolid Tested Against Vancomycin-Resistant Enterococci Isolated in Brazilian Hospitals

N/A
N/A
Protected

Academic year: 2019

Share "In vitro Antimicrobial Activity of Linezolid Tested Against Vancomycin-Resistant Enterococci Isolated in Brazilian Hospitals"

Copied!
9
0
0

Texto

(1)

F"

In vitro

) *!+ ,- !". )+/

! -! '!

2!5 2!2 (% % % ) "

22'$ 4 2 ,,%+",3

4%),3 '(+",3

/$,' 0' '7 ' ''& !($'' 2/$' $G +$$ !++$%):>2/$ + ,0' ! + + + $' $+ ' ' 2/ + '0' , ! $+ 0' ', $67+ 0' , ' 2$'$ ' , 67+ 0' ''' + '$ 9+H +$002/$+' ' 0$ '0 $ %> $' , ',9+7 +, ' '' $ +2/$7$0' ' &%* %C ( 2 +D # 4 + 4 + 4 + 0 #I' '4 +'J D # 4 +K' #L2/$+ $' $ , $ ' &( ' 2 '+,+7,' +$ &#36(2 $ '0' + ,$ ' ''$ ,%>>@ $ $'+=+ 2M+H +' +$ + '0, $+'2/$ '+,,,$$$

$ ++ 0' ' ,$ +2

/$ $'$ ++ +$+' + $ 0' '7 ' ''' 2

F " 0' '7 ' ''9+H +7 ' ' ' 2

$.L5%* .E

:B9-,))%&%%+ M:%, 1,% 0,?%A :,% '% %/%%2%AT.%5%,)J/%, IM/1$%%ADF)J/%,A)/K:0BF"( E"I%3,/ BL(LD(LDE(F"" 5%7BF"(""D(L

/$5 ' BF"(

O*G %3,%%,%% 07/, ,, .

F"(LED

* *--+** - 1 ,B+0G +*, **- *-* 0*> , 01-*,* L */*1+0*-0 +

, ** * 0 -GU#V4 *1 ,* 0 /*.- 1, * 0 0*, * +G * * / G ** ,"%W*#P'P. #OW*#PP(U!V6." 6."

(2)

FF

4 B+* * 10G --* * **+-+ *,--*10G - +*1*-*--*& 0 G0&& 0 D&40 && E* ,*--*& 40 && 0 -+ G+ -*0 * UOV* +*+*-/, *, -0J 310G --* --*10G - + 00+, .0 *1****, 003 00 G*UOV1 *1* *, * 3(4.3(.3(. 3(UO.(V - *+ 6"(06".3 6 .3( 3 03 0/0 * / G *+- , 00G

3(1UO.(V

4 +-.37 1*#P'".1 ,73 0G 0G ** >*0,**0 *, >*0* 7 * +*#PP).*+ >*0U)V; 0G./ 0 ,73 ** ; 0* -* 0*F +0 *G; 3 * 0*> *G - 1. 0** 0*, */ 0*0 ** 0**0 58- .+11*1 0 0 ** *U'V **.7*0 3*1 583 */ 0-* 0 0 *F +0U'V,**1** *- 1 *0G** 3** -* 0 / 1*,,-* 0UOV

1 ** *,7*,1 * -*,7*, * ,0** , -+* 1, *+8 &-**/*, *. -++ 0*>0* B+*+-**L 0,-** / 0G --/, 0** 0+*/ 0 +*,*+ 0*, *1*, * +G *, / G *&* 6." , -0* 2* ,*+*, *UP.#"V* C*1. B+*+-**L 0,-** * 0* - *,* 00G , 2* , *+ *, *. * 0-+* ,6."*, * ]3+1* ---* ^U##V **. * B+*+-**L 0,-** 16."

/* *4* .- * 00G*F +0U'V

*>0*D, 00G&#"")((E* J >0**. ** * 0 0 +0 23 ** * 0 1U##&#%V* -+*** , *,*** * -0J + 3* %"*.4.*** *, 5! 5%. ,;&4U$.#%.#$V(3" "(3"3+* / 0*>0* *1*,* ** * 0 */*G 1 *+0** 8 & -**/- 1* 0+*17.* *00*&* *,'%!1 '%!1 %"$"$". -* *00*&* -+ *.

1("-- 7""(1( 4 + "$" --.

+%%-- +3-- 0 + -*00*>0*U#OV

*>0** * * 1 *+ -*0 1 *.+*-0 G * * 0 */*G 1 * *,-+ *. "$.""0 6 %."(( U#OV **. + * +*B+ * , *. &* 3* 0 , ** * 0 1* *. * 0 ,- ++ ** * /G03* G 0 03* * , * +*1 -GU$.#OV

*+G3 + / 0+ "(3"

*/*G , J >0** 0*>0* 1 * / G *&* **0 * >*0* -* 0

! !

* 0 *

*G&/ G ** *0 3 0G>. #)( ." #(6 ." *3*0 ,- * -* 0*> ,003*1-* 0NF +0 -* 0&5 0*/*G,F +0.F +0 D'6."EM3 0+>-* 0.F +0 D$6 ."EM -* 0 /* 60* + 0. F +0 D!6 ." (6 ."EM ; 0* -* 0.F +0D'

(3)

F !%,.*&3,

24** * 0 */**,0*>0* , -+ 1 * 0** 0*0 ,/ G * * *

;** * F +0.F +0D!6."

#6."EM-* 00?* H[ 5 0*/*G, H.+** D#6."E 0G#*0 -- *3 * 0+*+G *0 3**,*- *0/0+*1 /* 0* * 0 *G 5 20 . 0U#(V

+ -**0*G

-03G* *0+* ,003*1 * 0*,0** 0 G DE * U#)V**+***G *D;E3 *,0*>0*.B+*+-**& 0,-**.

!,:µ;0<

:o

< !,50 !,90 # =

( *>0* !" !" #[! #"""

."D#(E A+*+-**L _' _' $&_' "" 0,-**

* -0 * _#( _#( _#( "" 7 G * _#( _#( _#( "" 4-* *00* #O $" "O[' #""" 8 * * _#""" _#""" _#""" "" -G * ≤#""" ≤#""" ≤#""" #""" JG G 0* !" $" ≤"O&$ #""" GG * _' _' _' "" 0 -* 0 _#( _#( '&_#( #'' *, -* !" _!" !&_! ""

( *>0* !" !" #&! #"""

."D#)E A+*+-**L $" _'" #&_' ##' 0,-**

(4)

FE !%,.*&3,

%4** * 0+ -**0*G, 0** 0*0 ,/ G ** *

5 a

!m;0:<b

>1c

:o

< 0 d

?;d d

4d

, d

#d

6." !DE _'DE "ODE !DE 'DE ! DE D#(E #DE _'DE #DE !DE _#(DE _! DE #DE 'DE !DE !DE _#(DE ! DE !DE _'DE #DE !DE _#(DE ! DE !DE _'DE #ODE $DE _#(DE _! DE !DE $DE #ODE ≤"ODE 'DE _! DE #DE _'DE #ODE !DE _#(DE ! DE #DE _'DE #ODE $DE _#(DE _! DE !DE _'DE "ODE $DE _#(DE _! DE ; !DE _'DE %DE !DE _#(DE ! DE !DE _'DE (DE !DE _#(DE _! DE #DE 'DE 'DE #DE 'DE ! DE !DE _'DE #ODE $DE _#(DE _! DE !DE 'DE #DE !DE _#(DE ! DE !DE _'DE #DE $DE _#(DE _! DE & #DE _'DE $DE #DE _#(DE ! DE

6." #DE $DE _#(DE ≤"ODE $DE _! DE D#)E ; !DE $DE _#(DE ≤"ODE 'DE _! DE 4!

& !DE $DE _#(DE ≤"ODE 'DE _! DE 4# ; !DE $DE _#(DE ≤"ODE 'DE _! DE 4# ; !DE $DE _#(DE ≤"ODE 'DE _! DE 4% ; !DE $DE _#(DE ≤"ODE 'DE _! DE 4$ &5 !DE #DE _#(DE $DE _#(DE _! DE ; #DE #DE _#(DE !DE _#(DE _! DE !DE $DE _#(DE #DE _#(DE ! DE 4# !DE $DE _#(DE ≤".ODE _#(DE _! DE 4! !DE $DE _#(DE ≤"ODE !DE _! DE 4# & !DE $DE _#(DE ≤"ODE 'DE _! DE 4# !DE $DE _#(DE !DE $DE _! DE 4# ; !DE $DE _#(DE ≤"ODE 'DE _! DE 4# ; !DE $DE _#(DE ≤"ODE 'DE _! DE 8 ; !DE _'DE _#(DE #DE _#(DE _! DE #DE _'DE _#(DE !DE _#(DE _! DE 4#

a

9)/X)J/%,9:%, 9H0XH%,039:%, 9)/MX9:%,)./Y,M%%, )1X)%%1%,% 9:%, )0()/X)%%0%%)J/%, 90(/$I9:%,0,?%/%%2 b

)B:, B!% $B% ,,,% %.%!*10A≥Eµ!&A:,%10A≥E!!&* !*10A≥E!!& % ,.,%%!10AZ!!& c

!%,B>X4:%,: !:X %!:,, 7*X7**, 0 ,X ,%!: , $X%!: d

(5)

FD !%,.*&3,

>258- ,'*1 043*1J -0,/ G *&*

(."3*58- D0 #&(E D0 )&#!E,*,,-* 0 3 ***0 * G*,,, G0G3 λN$'OC0 0

(6)

FL

-* *00*.JG G 0*. 0 -* 0.*, -*. 1 * *.-G *.GG *./ G * * -0 *U#'V+ 0*3+-* O0,;+00&** "O; 5 0 +**G . O"µ 3 ,#",;+00* *J300 * +0++-*3 -- .#""µ ,*+-*3 , -0 300 -0 3* + %O°* * * * + ,#(!"/ G *+0 3*- ,!$,* + * -0 3 1*> + -*0. ** * . *1+ -**0*G 1 0* ,*0+*GU#'V

2-*,+ -**0*G * . - */0GNB+*+-**L 0,-** ≤#µ1L

≥$µ1LM*, -* ≤#µ1L ≥$µ1LM 0 -* 0 ≤'µ1L ≥%!µ1LM JG G 0* ≤ $µ1L ≥ #(µ1LM * -0 * ≤ 'µ1L ≥ %!µ1LM / G * ≤$µ1L ≥%!µ1LM -* *00*

≤'µ1L ≥#(µ1LMGG * ≤"Oµ1L

≥'µ1L.1 * * ≤O""µ1L _O""µ1LD*10/0EM-G * ≤#"""µ1L _#"""µ1LD*10/0E0*>0* *-*1 ** 3 ,* ≤$µ1L + -**0*G ≥#(µ1L* U#PV B+ 0*G 0 *'64!P!#%

6."4!P!#!3 013* 0** 0*0 * ,

;0 +0 G-*1

*30 +0 G-+*158 *G, 00. 0U!"V* **1* , 043 -,3*'Ι

+0 * *, 130/* #W 1 103*5&GD*& *.* .4.4E-+0* -,O%"/!% #%° (7L 58- 3 *** 0*,G /G .**0 *,G*,,, G0G#% . *,,*,G*,,G$

#

0#3; ***O"W P"W , *0 D;O" ;P". - */0GE.;/ * * - 1, + -*0 *, -+/ 0+ 0G0*>0**** 00*0 ,- * + -*0 2-*D≤$µ1LE *1; ,* -+3 !µ1L 0!-;+0,0*>0* #" ** * 0 1 1 * 00*0 / 0+

4J- .B+*+-**L 0,-**3 -"(3" */*G 1 *."3*#""W , *3*1* * -+U%V 416."0#O,#)*0 D''!WE3 * B+*+-**L 0,-**

*10/0* -G *3 1 *0 / 0+ JG G 0*3J 00"(3" */*G 1 *- *DP$#W+ -**0*G 1

6 ." #""W + -**0*G 16 ."E . *1 0/0 * 1 * *3 /*- *3*#""W ,*

0 -* 03 */*G 1 *6.".3*($)W,+ -**0*G. + - */*G 1 *6 ." D'#!W * ED 0!E

4-* *00*3 /G */ 1 *6."

3* #""W + -**0*G. + , 6 ."*0 3+ -*0 -* *00*

0 +0 - , * 3 0 # , #(( ."

+*0 +0 G-*1.#" +*B+0 +0 - .3* 3 00 ( **1 *0 0 3 +*B+ 0 +0 - ** ,- 3 0030/,#)(."

D)#WE *3 +*B+ 9- 3* 3 004*- -$+G-4#.4!.4% 4$O **1 * ** 58- .3* 3 00.8. ..

(7)

F

*>0*3 */ -+ 1 * + 00 *,+0** *3 0G ** * 0 1 */ 1 * 00*0 + -*0 2-*D#""W+ -**0*GED 0#E * 13*-+0* +*3* 3 J +*B+ 0 ,G* ** * 0 * *

"(3" */*G 1 *+0** 8 &-**/ *.* 0+*1/ G *&* *U#OV6

***J 00"(3" */*G."(3"3

+*3** /3+0 - 0 ,/ G *,J-* 0G* , *+ *, * + (- U#%V * * 3* ** * 0 ***,-*G*.+ 0 -* 0. 0*. 0* *. -1 *. *10G *. G 0*. / U$.!#V

4 J- . -1 * * * B+*+-**L 0,-**3- */*G 1 *6 ."U%V3/. -* */*G,* -+D''!W* E 1 *6."+ - *> 0-*: +-U!!V* B+*+-**L 0,-** * 3*- ,4 8 1.3* G0 , G0G> -1 * 4 1 0 G0 , 13.3. 3 -* -G0 -*U#"V-* -1 -* 0 - ,3.4. 1 400 1 / - 1 -G0 **0 .+0G1 * 1 * 1 * 3*- 1 **0 , &* 3* 0* 0* *+ *,* *** 0 1U#"V

* ** * 0 1J**-"(3"

*/*G 1 * *.-*, ,/*, **1 00G* * 10G --* β&0 * *10G *++G. 3* 0#. 1 *10G * +

G* 0*, *.0G-G * 3 B+ "( 3" */*G 1 * / G ** **10/0* -G *3 1*0 / 0+ 3/. 00*0 3*10/0 * 1 * *

*0 0G.-**01G, 0 *, *3 -0G++ 0 2, * ** G G-*1 3/. --0* *,0 +0 0+, 10G --*&* * -/* 1 **1**-0. . 0G. 5 8 3 + , + 0 , -**01* 0 / 0+ * , * 0 0*, *UO.!%V40+1 / +,- * ,*, * + G10G --*&* / * 0+, */0/*1* *10 +0*-0 * ,6 ." . * - * +0 .6."UOV

- , *10 *,7 - , + , 9*G, 0+ / ,* *10 -* 0+*3/.*-* 0- ,7 0-. *3 .** . *+ 0 ,,- *UO.!$V

,**1,/ 0 *3*** 0**0 58- **,,* 0 *++G 10G+11*-* 0- ,/ G * * ." 6."5++* */*1 ,** *, +0** *

*0 0G. -*,- * *, 3*73J0G0**U$.!OV0G 00 L+ 00 0** 0* 0 0 -/ 0+ -+* -*,7*, *. * 0+*1JG G 0*.*, -* *. 0 -* 0. 0 */ *+ * *U%.!OV

**J 00"(3" */*G 1 * 7*0 3*-+G */ 0 */*1 *.* /+ 00*>0* -+ *1 , 0** 0+ * 0** 0* 0 */0/*1-* 0*>- *3*2*,*+ -+* U#OV+.*+G-"(3"

(8)

*, * 3*00/G0-,+0* 0,0*>0** ,*, * +G +0** ** >*0

-$

+J-** 28*0 + D3 0+>-* 0E. *8+* F 8* +D-* 0/*+0* + 0E.* 0 0F ; * + D-* 0 ; 0* E.* * ;** D ;** * +0E * ; 00 D-* 00?* HE.32*0G +7*0 ,*+G: 0 2 0 4 8 03-/*+3* * *0+* G. *1;, *

0+--#

&1A)%,%!%)A!(M.%1A%,%( , * !%, 8 % ,3% .%!* % 0,9:M:!,%))) BDE(" !M1A5 &A1%VA%,0,

.%!*(% % % !!* :%,B%*:%%% 0,9:M:!,%))) BE(

" % /. % % H%! =%!*( %M=$MG%!(MTA QH,R :B%:.!Q,*A"rd

A ,%!%* % R

F 0 PAV%1&A)%,%%$T&3,A% 7%3,A %!!,(% 6%!(:. %%, 0,

<>>> "BFE(

P SA /A 1 A ):,, 0::.,*::%0, 1,$.%)); LBL(E

E %:% 1A :% 5A 0.%, /A 1 ):* ,*:: %

%%% ,% ! 0 ! %))C FB(

D %,,%(0%&1A)3%0A1%&G5A%,!

=%!*(%%%%,%B% %,%3%)): BE(" L )%9)A$SA%,,09A%,!%, :,*4:%,:%% 6%!(:.!&%!%B$,! 6,%,)1$G6)1$G).,,%)*%3 <>>% B("

/A P% 1A 9%,,% 6A &.! 1 ):,* 4:%,: % %.%!*(%! TVAD!(!0 ! <>>> FEB(L

3% A &,4 $ M %:%!% %.* 4:(%,:%%%%%,% !0 ! %))) F"BD( &.!1>:%,:%,3,B

A A % [! 0 ! <>>> FEB"FD(

P%/A&.!1.*,3,%% !,(% 6%!(:. %% ! . :%, T V! ! 0 ! <>>> FB("

" ) , GA G %.(M,:, 0A 1,, $0A M,:, 61 . 7%3, ,3,%:3,7:!%,%(%!%, %%%%,%.%!*( %%%% ,%! 0 ! %))) F"BLD"(E

F S86A)45A)=A%,"%. ,3,%%!:%6%!(:.%%,

:% , .%!*(%

! 0 ! %))) F"B(E

0,!A1%8 %!&3,<>>> BL(D E 5%8,%!$A)% !AG7%&1MB 1%*A/$A%AMA/%,,A1A%,( 1%%, 0,%, 1,* Dth

!% )*1,*P% A0AT)%))) :D("

D S%%, 0!! 0,%, &%%* )%% S00&)(1 ,%!%,:,* %% %%%,,*A (::. %%1D(P%*A=,,%.%A/A<>>>

L S%%,0!!0,%,&%%*)%% S00&) ( /!% %% %!%, :,* !%%,::,! 1()P%*A=,,%.%A/A<>>>

9%!,0A)%:A1!%VA50P&3,A %, %%<>>> LBE(F /%,,1A$SA)%9)0 !!%,

%! %%,* * :,(, , ,: BA9(0,%,1,*/ 9%8A)1/P% 0 T)%))< :(

(9)

51A&,4$.*,3,%%6%!( :.:% :* !0 ! <>>> FBDD(L

),%1A A/ ,:(9%APS 1 %! % 4:(%,: %!,%%%%,%!%!%,A % !%A % :%, :% P M: !0 ! <>>> FFBF""(E

" )%.0A/%,,1AV3*8*A%,0!:% ! ! % %

%%% ,%B ! ,%, :!,%%0,1,%)): "EB""D(" F *1AH:%,)1A0 1A%,H%8

!,( %%%% ,%

%%,.%,%.%!*%0, 1,%))- "BFL("

1%*MG%!:%* .%!*%M(MTA<>>>QH ,R :B:%!Q,*AFth

AA,% !%* % R

Referências

Documentos relacionados

Additionally, a significant decrease in total body fat percentage accompanied by a significant increase in total lean mass percentage was observed only in the HOP group.. Moreover,

Compounds isolated in the present study were tested for their antimicrobial activity against human pathogenic fungi and bacteria.. Besides microorganisms of medical importance,

Molecular epidemiology of high level aminoglycoside resistant enterococci isolated from patients in a university hospital in southern

Methicil- lin-resistant Staphylococcus aureus (MRSA) strains were also inhibited by some naphtho- quinones tested, whereas they were resistant to all the comercially

The new oxazolidinone linezolid and other antimicrobial agents used to treat Gram-positive infections were tested against 1,585 Gram-positive cocci; 1,260 staphylococci and

Antimicrobial activity and spectrum of linezolid compared to 10 other agents tested against 1,582 strains of staphylococci isolated in Latin America medical centersb. Zone diameter

In vitro activity of doripenem in comparison to selected antimicrobial agents tested against non-fermentative Gram-negative pathogens collected by the INVITA-A-DORI Brazilian

Sendo uma descrição imagética de transferência de movimento, compreende-se que houve a tentativa de mostrar o movimento que o vento faz na árvore, mas no